Mucosal delivery of the human immunodeficiency virus-1 Tat protein in mice elicits systemic neutralizing antibodies, cytotoxic T lymphocytes and mucosal IgA

By Marinaro M.   Riccomi A.   Rappuoli R.   Pizza M.   Fiorelli V.   Tripiciano A.   Cafaro A.   Ensoli B.   De Magistris M.T.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3972-3981

Elsevier

Access to resources Recommend Favorite

A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein

By Nakamura Y.   Kameoka M.   Tobiume M.   Kaya M.   Ohki K.   Yamada T.   Ikuta K.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 489-496

Elsevier

Access to resources Recommend Favorite

Binding of antibodies to human immunodeficiency virus type 1 (HIV-1)-infected lymphocytes elicited by vaccines and by natural infection

By Gorse G.J.   Patel G.B.   Arbuckle J.A.   Belshe R.B.  

Vaccine, Vol. 22, Iss. 3, 2004-01 ,pp. : 383-397

Elsevier

Access to resources Recommend Favorite

Cross-clade neutralizing antibody production against human immunodeficiency virus type 1 clade E and B' strains by recombinant Mycobacterium bovis BCG-based candidate vaccine

By Chujoh Y.   Matsuo K.   Yoshizaki H.   Nakasatomi T.   Someya K.   Okamoto Y.   Naganawa S.   Haga S.   Yoshikura H.   Yamazaki A.   Yamazaki S.   Honda M.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 797-804

Elsevier

Access to resources Recommend Favorite

Construction and characterization of a Salmonella typhi-based human immunodeficiency virus type 1 vector vaccine

By Fouts T.R.   Lewis G.K.   Hone D.M.  

Vaccine, Vol. 13, Iss. 6, 1995-04 ,pp. : 561-569

Elsevier

Access to resources Recommend Favorite